An investor, who purchased shares of Amyris Inc (NASDAQ:AMRS), filed a lawsuit over alleged violations of Federal Securities Laws by Amyris Inc.
Investors who purchased shares of Amyris Inc (NASDAQ:AMRS) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose thatin the first quarter of 2017, Amyris made a decision to take an equity stake in one of Blue California’s affiliates that focused on the sweetener market in lieu of cash payment under the license agreement, that consequently, due to Amyris’ decision, Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California, that and as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
Shares of Amyris Inc (NASDAQ:AMRS) closed on May 18, 2017 at $0.296 per share.
Those who are current long term stockholders of shares of Amyris Inc (NASDAQ:AMRS) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego